BARCLAYS PLC

Position in RGNX — REGENXBIO Inc.

CIK 312069 LONDON, X0

Back to RGNX Full portfolio

Position in RGNX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$527,922

-$37,115 QoQ

Shares Held

44,067

-34.6% QoQ

Ownership

0.067%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#69

of 163 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in RGNX Over Time

Shares Held

Position Value (USD)

Derivatives in RGNX

reported options exposure · as of Mar 31, 2026

CallValue

$224,584

CallShares

26,800

PutValue

$224,584

PutShares

26,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,173 across 455 Biotechnology names. RGNX ranks #161 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

All Filings in RGNX

Export CSV

38 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$527,922	44,067	-34.6%	Shares	Defined	2026-08-14
2026-03-31	$224,584	26,800	0.0%	Put	Defined	2026-05-15
2026-03-31	$224,584	26,800	0.0%	Call	Defined	2026-05-15
2026-03-31	$565,037	67,427	-59.0%	Shares	Defined	2026-05-15
2025-12-31	$2,367,662	164,421	-27.2%	Shares	Sole	2026-02-13
2025-12-31	$385,920	26,800	+25.2%	Put	Sole	2026-02-13
2025-12-31	$385,920	26,800	+25.2%	Call	Sole	2026-02-13
2025-09-30	$206,510	21,400	0.0%	Call	Sole	2026-03-31
2025-09-30	$206,510	21,400	0.0%	Put	Sole	2026-03-31
2025-09-30	$2,180,321	225,940	-5.7%	Shares	Defined	2026-03-31
2025-06-30	$1,966,581	239,535	+100.2%	Shares	Sole	2026-02-27
2025-06-30	$175,694	21,400	0.0%	Put	Sole	2026-02-27
2025-06-30	$175,694	21,400	0.0%	Call	Sole	2026-02-27
2025-03-31	$153,010	21,400	-14.4%	Put	Sole	2026-03-17
2025-03-31	$855,561	119,659	-5.8%	Shares	Sole	2026-03-17
2025-03-31	$153,010	21,400	-14.4%	Call	Sole	2026-03-17
2024-12-31	$982,211	127,065	+9.5%	Shares	Sole	2026-03-19
2024-09-30	$1,217,090	116,024	+141.3%	Shares	Sole	2026-03-31
2024-06-30	$562,488	48,076	-2.8%	Shares	Sole	2026-03-23
2024-03-31	$1,041,953	49,452	-55.8%	Shares	Sole	2026-03-24
2024-03-31	$526,750	25,000	—	Call	Sole	2026-03-24
2024-03-31	$526,750	25,000	—	Put	Sole	2026-03-24
2023-12-31	$2,010,471	112,004	+36.9%	Shares	Defined	2026-03-24
2023-09-30	$1,346,543	81,807	-9.4%	Shares	Defined	2026-03-26
2023-06-30	$1,804,597	90,275	+35.2%	Shares	Defined	2026-03-27
2023-03-31	$1,262,204	66,748	-30.9%	Shares	Sole	2026-03-30
2022-12-31	$2,191,069	96,608	+13.5%	Shares	Sole	2026-03-30
2022-09-30	$2,250,382	85,145	+470.3%	Shares	Defined	2022-11-03
2022-06-30	$368,771	14,930	-68.6%	Shares	Defined	2022-08-12
2022-03-31	$1,578,050	47,546	-29.4%	Shares	Defined	2022-05-16
2021-12-31	$2,203,097	67,373	-0.4%	Shares	Sole	2022-02-14
2021-09-30	$2,835,007	67,629	+93.0%	Shares	Defined	2021-11-09
2021-06-30	$1,361,225	35,038	-50.3%	Shares	Sole	2021-08-13
2021-03-31	$2,404,685	70,498	+73.8%	Shares	Sole	2021-05-13
2020-12-31	$1,839,528	40,554	-43.5%	Shares	Defined	2021-02-11
2020-09-30	$1,975,082	71,769	-19.3%	Shares	Sole	2020-11-12
2020-06-30	$3,276,507	88,963	-1.3%	Shares	Defined	2020-08-12
2020-03-31	$2,918,247	90,125	—	Shares	Defined	2020-05-13
No filing history on record for this holder in this stock.